Eye Care Market is Anticipated to Witness High Growth Owing to Increasing Prevalence of Eye Disorders

 


The eye flu or conjunctivitis market comprises products that are used to alleviate symptoms and treat various eye infections and disorders including bacterial conjunctivitis, viral conjunctivitis and allergic conjunctivitis. Conjunctivitis, commonly known as pink eye, refers to redness and inflammation of the conjunctiva which is a thin transparent layer that lines the inner surface of eyelids and covers the white part of the eye. It is a highly contagious condition that may result in symptoms like itching, discharge, tearing of eyes or formation of crusty eyelashes. Rising awareness regarding eye disorders and increasing cases of conjunctivitis across age groups are driving the demand for eye flu treatment and prevention drugs, eye drops and ointments.

 The Global eye flu (conjunctivitis) Market is estimated to be valued at US$ 4.54 Bn in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period 2023 to 2030.

Key Takeaways
Key players operating in the eye flu (conjunctivitis) are Novartis AG, Allergan, Bausch Health, Santen Pharmaceutical, Johnson & Johnson, Alembic Pharmaceuticals, Akorn Pharmaceuticals, Alcon, Pfizer, Valeant Pharmaceuticals, Merck & Co., Similasan Corporation, Sun Pharmaceutical Industries, Prestige Consumer Healthcare, Lupin Pharmaceuticals, Alembic Pharmaceuticals, Aurolab, Intas Pharmaceuticals, Sun Pharma, Cipla. These players are focusing on new product launches and expansions to strengthen their market position.

Some key opportunities in the eye flu market include increasing focus on development of long-acting eye drops which require less frequent administration and provide convenience to patients. Manufacturers are also exploring opportunities to develop combination therapy drugs that can treat both viral and bacterial conjunctivitis.

Globally, companies are eyeing high growth markets in Asia, Africa, and South America through acquisitions and collaborative partnerships with regional players. Establishing manufacturing and distribution facilities in emerging countries allows them to serve local customers efficiently and cater to the unmet need.

Market drivers
Increased incidence of allergic conjunctivitis owing to rising environmental pollution and changing demographics is a major market driver. Growing awareness about eye care and regular screening through social media campaigns and eye check-up drives by optometrists is also propelling the market growth.

Market restraints
However, high treatment and product costs of premium medications pose a significant challenge. Lack of healthcare infrastructure and awareness in underdeveloped regions also restricts market expansion to some extent. Generic competition from local players also affects pricing of branded products.

Segment Analysis
The eye flu (conjunctivitis) market can be segmented into allergic conjunctivitis, bacterial conjunctivitis and viral conjunctivitis. Allergic conjunctivitis dominates the market as it accounts for majority of eye flu cases across the globe. Factors like increasing allergen exposure and changing environment have contributed to rising allergic conjunctivitis cases thereby driving the segment.

Global Analysis
North America currently accounts for the largest share in the eye flu (conjunctivitis) market owing to factors like rising healthcare expenditure and growing awareness regarding eye care. However, Asia Pacific is projected to witness the highest growth during the forecast period owing to rapid economic development, rising living standards and increasing healthcare investments across emerging nations like China and India. Additionally, increasing patient pool suffering from conjunctivitis and presence of key generic players offering low cost treatment options further aids market growth in Asia Pacific region.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more